January 4, 2018 / 6:37 AM / 20 days ago

BRIEF-Targovax: Immune Activation Data In Patients Treated With ONCOS-102

Jan 4 (Reuters) - TARGOVAX ASA:

* ANNOUNCES IMMUNE ACTIVATION DATA IN FIRST FOUR PATIENTS TREATED WITH ONCOS-102

* ‍RESULTS ARE IN LINE WITH DATA REPORTED IN COMPLETED ALL-COMERS PHASE I TRIAL​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below